Kisqali 600 MG daily dose UU 63S

Ended Awarded Last action

Contract number
SPE2DR26F5RS8
Awardee
Awarding agency
Obligated
$12,280

Award facts

Contract value 100% obligated
$12,280.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $12,280 delivery order to Amerisourcebergen Drug Corp on March 13, 2026, for KISQALI 600 mg daily dose tablets (63-count units), with a firm fixed price and an ultimate completion date of April 3, 2026.

Place of performance is Conshohocken, PA. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) with Cencora, Inc., valued at $999,999,999.00 through December 2026. This IDC supports pharmaceutical and medical supply procurement globally across military healthcare programs.

Quick answers

Who was awarded contract SPE2DR26F5RS8?

SPE2DR26F5RS8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 13, 2026.

How much is contract SPE2DR26F5RS8 worth?

The government has obligated $12,280 on SPE2DR26F5RS8.

Is contract SPE2DR26F5RS8 an order under another contract?

Yes. SPE2DR26F5RS8 is a delivery order under SPE2DR25D3003, an indefinite delivery contract.

Was contract SPE2DR26F5RS8 competed?

The extent of competition for SPE2DR26F5RS8 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award